Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
US8252545B2 · kind B2 · utility
0Cited by
8References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2010 |
| Grant date | Aug 28, 2012 |
| Priority date | — |
| Expiry date | May 19, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5743
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Immunogenic peptides of a melanoma antigen recognized by T cells, designated gp100, bioassays using the peptides to diagnose, assess or prognose a mammal afflicted with cancer, more specifically melanoma or metastatic melanoma, and use of the proteins and peptides as immunogens to inhibit, prevent or treat melanoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.